<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head><meta charset="utf-8"><title>Contents</title><meta bibliotech-encoding="wEncode"><style id="style-override"></style><script id="deleteme">var version="3.0.1";(function preprescript(){if(!window.parent)return;window.eventFlags={load:false,DOMContentLoaded:false};var setEventFlag=function setEventFlag(event){eventFlags[event]=true};window.addEventListener("load",setEventFlag.bind(this,"load"));document.addEventListener("DOMContentLoaded",setEventFlag.bind(this,"DOMContentLoaded"));window.api={inject:inject};window.msgParent=iframeMessager({targetWindow:window.parent,targetOrigin:window.location.ancestorOrigins&&window.location.ancestorOrigins[0]?window.location.ancestorOrigins[0]:location.origin,api:api});window.decode=decode;parent.postMessage("iframeMessagerReady","*");function decode(hash,sheet){sheet.insertRule("@media print { c { display: inline !important; } }",0);sheet.insertRule("@media print { w { display: inline !important; } }",0);hash.split("").reduce(function(p,c,i,a){return(i%3===0?p.push(c):p.push(p.pop()+c))&&p},[]).map(function(h){return h.split("").map(function(x){return parseInt(x,16)})}).map(function(i,j){return(!(i[0]&8)||!(i[1]&8)?"c:nth-of-type(42n+"+(j*2+1)+")":"")+(i[0]&8?"":",")+(!(i[0]&8)||i[1]&8?"c:nth-of-type(42n+"+(j*2+2)+")":"")+"{display:none}"}).forEach(function(x){sheet.insertRule(x,0)});var masks=transformHash(hash);masks.forEach(function(mask,i){var interval=mask.reduce(function(p,c){return p+c})+mask.length;var c=0;mask.map(function(b,j){return b?'[r="'+i+'"] > w:nth-of-type('+interval+"n + "+(j+1+c++)+")":""}).filter(function(s){return s}).forEach(function(s){return sheet.insertRule(s+" { display: none }",0)})});if(window.resizeTextDivs){setTimeout(resizeTextDivs)}function transformHash(hash){return hash.match(/..../g).map(function(h4){var bs=parseInt(h4,16).toString(2);while(bs.length<h4.length*4){bs=bs+"0"}return bs}).map(function(mask,i){return mask.split("").map(function(b){return Number(b)})})}}function inject(cb,script){var el=document.createElement("script");el.id="prescript";el.innerHTML=script;document.head.appendChild(el);if(cb)return cb()}})();function iframeMessager(opts){var id=0;var cbs={};if(iframeMessager.onMessage){window.removeEventListener("message",onMessage)}iframeMessager.onMessage=onMessage;window.addEventListener("message",onMessage);return messager;function messager(name,cb){var args=Array.prototype.slice.call(arguments,2);if(cb)cbs[id]=cb;var msg={type:"sendi",func:name,args:args,id:id++,cb:Boolean(cb)};opts.targetWindow.postMessage(msg,opts.targetOrigin)}function onMessage(e){switch(e.data.type){case"sendi":var handler=opts.api[e.data.func];if(handler){var cb=null;if(e.data.cb){cb=function cb(){var returnArgs=Array.prototype.slice.call(arguments);if(!(returnArgs instanceof Array)){returnArgs=[returnArgs]}var response={type:"recvi",args:returnArgs,id:e.data.id};e.source.postMessage(response,e.origin)}}handler.apply(this,[cb].concat(e.data.args))}break;case"recvi":var func=cbs[e.data.id];if(func){delete cbs[e.data.id];func.apply(this,e.data.args)}break}}}</script></head><body><span></span><nav id="nav" epub:type="toc"><h1><t role="text" r="0"><w> as</w><w>Contents</w></t></h1><ol><li><a href="copyright.html"><t role="text" r="1"><w>Contents</w><w>Copyright</w></t></a></li><li><a href="figures.html"><t role="text" r="2"><w> gastric</w><w>Figures</w></t></a></li><li><a href="chapter_1.html"><t role="text" r="3"><w> Ranitidine</w><w>1</w><w> Inhibitors</w><w>1</w><w> of</w><w> Fosinopril</w><w> angiotensin</w><w> converting</w><w> enzyme</w><w> as</w><w>6.1</w><w> effective</w><w> gyrase</w><w> antihypertensive</w><w> of</w><w> agents</w></t></a><ol><li><a href="chapter_1.html#sec_1_1"><t role="text" r="4"><w>References</w><w>1.1</w><w>5</w><w> Introduction</w></t></a></li><li><a href="chapter_1.html#sec_1_2"><t role="text" r="5"><w> of</w><w>1.2</w><w>8</w><w> Synthesis</w><w> Astemizole</w><w> of</w><w> Introduction</w><w> captopril</w></t></a></li><li><a href="chapter_1.html#sec_1_3"><t role="text" r="6"><w> channel</w><w>1.3</w><w> Synthesis</w><w>10.1</w><w> of</w><w> Enalaprilat</w><w> Valsartan</w><w> (2,</w><w> Fosinopril</w><w> R</w><w> =</w><w> H)</w><w> Quinapril</w><w> and</w><w> Introduction</w><w> Lisinopril</w><w> (3)</w></t></a></li><li><a href="chapter_1.html#sec_1_4"><t role="text" r="7"><w> receptor</w><w>1.4</w><w> anxiolytic</w><w> Quinapril</w></t></a></li><li><a href="chapter_1.html#sec_1_5"><t role="text" r="8"><w> seasonal</w><w>1.5</w><w> Benazepril</w></t></a></li><li><a href="chapter_1.html#sec_1_6"><t role="text" r="9"><w>References</w><w>1.6</w><w> Ramipril</w></t></a></li><li><a href="chapter_1.html#sec_1_7"><t role="text" r="10"><w> hypertension</w><w>1.7</w><w>3.2</w><w> Fosinopril</w></t></a></li><li><a href="chapter_1.html#sec_1_8"><t role="text" r="11"><w> Diazepam</w><w>References</w></t></a></li></ol></li><li><a href="chapter_2.html"><t role="text" r="12"><w>3.5</w><w>2</w><w> Blockade</w><w> of</w><w> Norfloxacin</w><w> angiotensin-II</w><w> Cimetidine</w><w> receptors</w></t></a><ol><li><a href="chapter_2.html#sec_2_1"><t role="text" r="13"><w>2.2</w><w>2.1</w><w> histamine-1</w><w> Introduction</w></t></a></li><li><a href="chapter_2.html#sec_2_2"><t role="text" r="14"><w> gyrase</w><w>2.2</w><w> Losartan</w></t></a></li><li><a href="chapter_2.html#sec_2_3"><t role="text" r="0"><w>9.3</w><w>2.3</w><w> of</w><w> Valsartan</w></t></a></li></ol></li><li><a href="chapter_3.html"><t role="text" r="1"><w> Introduction</w><w>3</w><w>References</w><w> Calcium</w><w> channel</w><w>References</w><w> blockers</w><w> in</w><w> Amlodipine</w><w> the</w><w> angiotensin-II</w><w> treatment</w><w> of</w><w> angina</w><w> transcriptase</w><w> and</w><w> hypertension</w></t></a><ol><li><a href="chapter_3.html#sec_3_1"><t role="text" r="2"><w> blockers</w><w>3.1</w><w>References</w><w> Introduction</w></t></a></li><li><a href="chapter_3.html#sec_3_2"><t role="text" r="3"><w> Synthesis</w><w>3.2</w><w> Nifedipine</w></t></a></li><li><a href="chapter_3.html#sec_3_3"><t role="text" r="4"><w>1.1</w><w>3.3</w><w> and</w><w> Amlodipine</w></t></a></li><li><a href="chapter_3.html#sec_3_4"><t role="text" r="5"><w>7.2</w><w>3.4</w><w> receptors</w><w> Diltiazem</w></t></a></li><li><a href="chapter_3.html#sec_3_5"><t role="text" r="6"><w> Introduction</w><w>3.5</w><w> Verapamil</w></t></a></li><li><a href="chapter_3.html#sec_3_6"><t role="text" r="7"><w> depression</w><w>References</w></t></a></li></ol></li><li><a href="chapter_4.html"><t role="text" r="8"><w>1.2</w><w>4</w><w> Antagonists</w><w> of</w><w> histamine</w><w> receptors</w><w> Verapamil</w><w> as</w><w> anti-ulcer</w><w> remedies</w></t></a><ol><li><a href="chapter_4.html#sec_4_1"><t role="text" r="9"><w> Flumezanil</w><w>4.1</w><w> Introduction</w></t></a></li><li><a href="chapter_4.html#sec_4_2"><t role="text" r="10"><w> blockers</w><w>4.2</w><w>Index</w><w> Cimetidine</w></t></a></li><li><a href="chapter_4.html#sec_4_3"><t role="text" r="11"><w>5</w><w>4.3</w><w> muscle</w><w> Ranitidine</w></t></a></li><li><a href="chapter_4.html#sec_4_4"><t role="text" r="12"><w> secretion</w><w>4.4</w><w> Famotidine</w></t></a></li><li><a href="chapter_4.html#sec_4_5"><t role="text" r="13"><w> Ramipril</w><w>References</w></t></a></li></ol></li><li><a href="chapter_5.html"><t role="text" r="14"><w> Lansoprazole</w><w>5</w><w> Proton</w><w>9</w><w> pump</w><w>References</w><w> inhibitors</w><w>3.3</w><w> as</w><w> and</w><w> gastric</w><w>1</w><w> acid</w><w> secretion</w><w> inhibitors</w></t></a><ol><li><a href="chapter_5.html#sec_5_1"><t role="text" r="0"><w> as</w><w>5.1</w><w> anxiolytic</w><w> Introduction</w></t></a></li><li><a href="chapter_5.html#sec_5_2"><t role="text" r="1"><w> DNA</w><w>5.2</w><w> angina</w><w> The</w><w> ‘Omeprazole</w><w>References</w><w> cycle'</w></t></a></li><li><a href="chapter_5.html#sec_5_3"><t role="text" r="2"><w> receptors</w><w>5.3</w><w>6.3</w><w> Synthesis</w><w> of</w><w> (3)</w><w> omeprazole</w></t></a></li><li><a href="chapter_5.html#sec_5_4"><t role="text" r="3"><w> Introduction</w><w>5.4</w><w> Lansoprazole</w></t></a></li><li><a href="chapter_5.html#sec_5_5"><t role="text" r="4"><w> as</w><w>References</w></t></a></li></ol></li><li><a href="chapter_6.html"><t role="text" r="5"><w>10.4</w><w>6</w><w> anti-ulcer</w><w> Modulation</w><w> receptor</w><w> of</w><w> of</w><w> central</w><w> HIV</w><w> serotonin</w><w> in</w><w> the</w><w> secretion</w><w> treatment</w><w> of</w><w> Enalaprilat</w><w> depression</w></t></a><ol><li><a href="chapter_6.html#sec_6_1"><t role="text" r="6"><w> ‘Omeprazole</w><w>6.1</w><w> Introduction</w></t></a></li><li><a href="chapter_6.html#sec_6_2"><t role="text" r="7"><w> Nifedipine</w><w>6.2</w><w>9.1</w><w> Fluoxetine</w></t></a></li><li><a href="chapter_6.html#sec_6_3"><t role="text" r="8"><w> for</w><w>6.3</w><w> Sertraline</w></t></a></li><li><a href="chapter_6.html#sec_6_4"><t role="text" r="9"><w> transcriptase</w><w>6.4</w><w> Paroxetine</w></t></a></li><li><a href="chapter_6.html#sec_6_5"><t role="text" r="10"><w>1.2</w><w>References</w></t></a></li></ol></li><li><a href="chapter_7.html"><t role="text" r="11"><w>8.2</w><w>7</w><w> and</w><w> Hypnotic,</w><w> treatment</w><w> anxiolytic</w><w> and</w><w> anticonvulsant</w><w>1.6</w><w> and</w><w> muscle</w><w>1.4</w><w> relaxant</w><w> reverse</w><w> agents</w><w> Lansoprazole</w><w> acting</w><w> of</w><w> at</w><w> Cimetidine</w><w> the</w><w> benzodiazepine</w><w> Nifedipine</w><w> receptor</w></t></a><ol><li><a href="chapter_7.html#sec_7_1"><t role="text" r="12"><w>10.4</w><w>7.1</w><w> Introduction</w></t></a></li><li><a href="chapter_7.html#sec_7_2"><t role="text" r="13"><w> Introduction</w><w>7.2</w><w> Zidovudine</w><w> Diazepam</w></t></a></li><li><a href="chapter_7.html#sec_7_3"><t role="text" r="14"><w> angiotensin-II</w><w>7.3</w><w> Alprazolam</w></t></a></li><li><a href="chapter_7.html#sec_7_4"><t role="text" r="0"><w> and</w><w>7.4</w><w> Zidovudine</w><w> Flumezanil</w></t></a></li><li><a href="chapter_7.html#sec_7_5"><t role="text" r="1"><w> Zolpidem</w><w>7.5</w><w> Introduction</w><w> Zolpidem</w></t></a></li><li><a href="chapter_7.html#sec_7_6"><t role="text" r="2"><w> Introduction</w><w>References</w></t></a></li></ol></li><li><a href="chapter_8.html"><t role="text" r="3"><w>5.4</w><w>8</w><w> Another</w><w> antibacterial</w><w> histamine</w><w> Introduction</w><w> receptor:</w><w> blockers</w><w> of</w><w> the</w><w>10.2</w><w> histamine-1</w><w>6.2</w><w> receptor</w><w> Diltiazem</w><w> for</w><w> the</w><w> Another</w><w> treatment</w><w> of</w><w> seasonal</w><w> allergic</w><w> rhinitis</w></t></a><ol><li><a href="chapter_8.html#sec_8_1"><t role="text" r="4"><w> Inhibitors</w><w>8.1</w><w>8.3</w><w> Introduction</w></t></a></li><li><a href="chapter_8.html#sec_8_2"><t role="text" r="5"><w>4.4</w><w>8.2</w><w> Modulation</w><w> Terfenadine</w><w>5.4</w><w> and</w><w> muscle</w><w> Fexofenadine</w></t></a></li><li><a href="chapter_8.html#sec_8_3"><t role="text" r="6"><w> Cimetidine</w><w>8.3</w><w> Loratadine</w></t></a></li><li><a href="chapter_8.html#sec_8_4"><t role="text" r="7"><w> of</w><w>8.4</w><w> captopril</w><w> Cetirizine</w></t></a></li><li><a href="chapter_8.html#sec_8_5"><t role="text" r="8"><w> the</w><w>8.5</w><w> Astemizole</w></t></a></li><li><a href="chapter_8.html#sec_8_6"><t role="text" r="9"><w> reverse</w><w>References</w></t></a></li></ol></li><li><a href="chapter_9.html"><t role="text" r="10"><w> the</w><w>9</w><w> of</w><w> Nucleoside</w><w> anaologues</w><w> which</w><w> inhibit</w><w>6.3</w><w> HIV</w><w> reverse</w><w> in</w><w> transcriptase</w><w> Ranitidine</w><w> as</w><w> anti-AIDS</w><w> (AZT)</w><w> drugs</w></t></a><ol><li><a href="chapter_9.html#sec_9_1"><t role="text" r="11"><w> Antagonists</w><w>9.1</w><w> =</w><w> Introduction</w></t></a></li><li><a href="chapter_9.html#sec_9_2"><t role="text" r="12"><w>2.3</w><w>9.2</w><w> Zidovudine</w><w> (AZT)</w></t></a></li><li><a href="chapter_9.html#sec_9_3"><t role="text" r="13"><w>7</w><w>9.3</w><w>10.4</w><w> Lamivudine</w><w> blockers</w><w> (3-TC)</w></t></a></li><li><a href="chapter_9.html#sec_9_4"><t role="text" r="14"><w>6.4</w><w>References</w></t></a></li></ol></li><li><a href="chapter_10.html"><t role="text" r="0"><w> Ciprofloxacin</w><w>10</w><w> Inhibitors</w><w> Quinolones</w><w> and</w><w> as</w><w>3.2</w><w> antibacterial</w><w> as</w><w> DNA</w><w> gyrase</w><w> inhibitors</w></t></a><ol><li><a href="chapter_10.html#sec_10_1"><t role="text" r="1"><w>1.6</w><w>10.1</w><w>3.3</w><w> Introduction</w></t></a></li><li><a href="chapter_10.html#sec_10_2"><t role="text" r="2"><w> omeprazole</w><w>10.2</w><w> receptors</w><w> Norfloxacin</w></t></a></li><li><a href="chapter_10.html#sec_10_3"><t role="text" r="3"><w> anxiolytic</w><w>10.3</w><w> Ciprofloxacin</w></t></a></li><li><a href="chapter_10.html#sec_10_4"><t role="text" r="4"><w> of</w><w>10.4</w><w> histamine</w><w> Ofloxacin</w><w> and</w><w> Levofloxacin</w></t></a></li><li><a href="chapter_10.html#sec_10_5"><t role="text" r="5"><w>2.3</w><w>References</w></t></a></li></ol></li><li><a href="abbreviations.html"><t role="text" r="6"><w> gyrase</w><w>Abbreviations</w></t></a></li><li><a href="index.html"><t role="text" r="7"><w> Diltiazem</w><w>Index</w></t></a></li></ol></nav></body></html>